Clinical Trial Update: Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating metronomic cyclophosphamide and etoposide for advanced head and neck squamous cell carcinoma; status is not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Etoposide (Etoposide)

Snippet

Sponsor: National Cancer Institute, Egypt | Conditions: Squamous Cell Carcinoma, Advanced Head and Neck Cancer | Phase 2 | Status: NOT_YET_RECRUITING